Viewing Study NCT04501094


Ignite Creation Date: 2025-12-25 @ 1:38 AM
Ignite Modification Date: 2025-12-27 @ 11:04 AM
Study NCT ID: NCT04501094
Status: TERMINATED
Last Update Posted: 2022-03-22
First Post: 2020-08-05
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Phase II Study of Bintrafusp Alfa (M7824) in Checkpoint Inhibitor Naive and Refractory Subjects With Urothelial Carcinoma
Sponsor: National Cancer Institute (NCI)
Organization: